Clinical Trial Update: Efficacy of Oral Semaglutide in Overweight or Obesity [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the efficacy of oral semaglutide in individuals with overweight or obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• oral semaglutide (semaglutide)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Obesity, Weight Loss | Phase 4 | Status: UNKNOWN